Search Results 121-130 of 8563 for zerona

1. Eliminating Breast Cancer Surgery in Exceptional Responders with Neoadjuvant Systemic Therapy - Mayo Clinic

   This is an investigational study. Radiation therapy is delivered using FDA-approved and commercially available methods. The study doctor can explain how ...

2. A Study to Evaluate AVB-S6-500 with Paclitaxel vs Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer - Mayo Clinic

   The purpose of this study is to evaluate AVB-S6-500 in combination with paclitaxel (Pac) in patients with platinum resistant recurrent ovarian cancer to compare ...

3. Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy - Mayo Clinic

   About this study. This study is an observational study to determine predictors of sudden cardiac death or appropriate ICD therapy in patients with ...

4. A Study to Assess Feasibility and Benefit of a Patient-reported Outcomes Quality of Life Tool for Hematology and Medical Oncology - Mayo Clinic

   The purpose of this study is to determine the feasibility and benefit of a patient-reported outcomes quality of life tool for hematology and medical oncology.

5. A Study to Evaluate Rozanolixizumab to Treat Patients with Generalized Myasthenia Gravis - Mayo Clinic

   The purpose of this study is to assess the safety, tolerability, and effectiveness of additional 6-week treatment cycles with Rozanolixizumab in study ...

6. A Study of Long-Term Outcomes of Cardiac Resynchronization Therapy Recipients with Congestive Heart Failure - Mayo Clinic

   The purpose of this study is to determine the long-term outcome of cardiac resynchronization therapy (CRT) recipients with congestive heart failure and any ...

7. Synergy with Grid Therapy and Immune Checkpoint Inhibitors in Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   The primary objective of this study is to describe the safety and toxicity of grid + immunotherapy in stage IV NSCLC using CTCAE v5.0. Participation eligibility.

8. Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma - Mayo Clinic

   This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma.

9. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis - Mayo Clinic

   The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of 12 weeks of RO7303509 treatment in patients with systemic sclerosis ( ...

10. Nonmelanoma Skin Cancer Clinical Trials - Mayo Clinic Research

    The purpose of this study is to use new technology called Optical Transfer Diagnosis (OTD) to find if skin lesions are melanomas or non cancer. The research ...